Chronic kidney disease

Nephrology and Urology of Small Animals

Volumn , Issue , 2010, Pages 433-471

  Polzin, David J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85100611128     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118785546.ch48     Document Type: Chapter

References (134)

1. Abbate, M., et al. (2006). How does proteinuria cause progressive renal damage? J Am SocNephrol 17: 2974-2984.
2. Adams, L., et al. (1994). Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Lab Invest 70: 347-357.
3. Adams, L., et al. (1992). Correlation of urine protein/creatinine ratio and twenty-four-hour urinary protein excretion in normal cats and cats with surgically induced chronic renal failure. J Vet InternMed 6: 36-40.
4. Adrogué, H. and N. Madias (1998). Management of life-threatening acid-base disorders. N Engl J Med 338: 26-34.
5. Akizawa, T., et al. (2003). New strategies for treatment of secondary hyperparathyroidism. Am J Kidney Dis 41: S100-S103.
6. Almaden, Y., et al. (1996). Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11: 970-976.
7. Anderstam, B., et al. (1996). Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am SocNephrol 7: 2453-2460.
8. Andress, D.L. (2006). Vitamin D in chronic kidney disease: a systemic role for selective vitamin receptor activation. Kidney Int 69: 33-43.
9. Atkins, C.E., et al. (2007). The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensinaldosterone system in the dog. J Vet Pharmacol Ther 30: 394-400.
10. Bagga, D., et al. (2003). Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100:1751-1756.
11. Bahlmann, F.H. and D. Fliser (2009). Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens 18: 15-20.
12. Barber, P., et al. (1999). Effect of dietary phosphate restriction on renal secondary hyperparathyroidism in the cat. J Small Anim Pract 40:62-70.
13. Barber, P. and J. Elliot (1998). Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 39: 108-116.
14. Belew, A., et al. (1999). Evaluation of the white-coat effect in cats. J Vet Intern Med 13: 134-142.
15. Bidani, A.K. and K.A. Griffin (2004). Pathophysiology of hypertensive renal damage. Implications for therapy. Hypertension 44: 595-601.
16. Block, G., et al. (1998). Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617.
17. Board, NKFKDOQIA. (2002). Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4.
18. Definition and classification of stages of chronic renal failure. Am J Kidney Dis 39: S46-S75.
19. Boyd, L.M., et al. (2008). Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med 22: 1111-1117.
20. Brenner B.M., et al. (1982). Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in ageing, renal ablation, and intrinsic renal disease. NEngl J Med 307: 652-659.
21. Bro, S. and K. Olgaard (1997). Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 30: 606-620.
22. Brown, S.A., et al. (1991). Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 1: 1169-1179.
23. Brown, S.A. (2008). Oxidative stress and chronic kidney disease. Vet Clin North Am Small Anim Pract 38: 157-166.
24. Brown, S.A. (2007a). In: BSAVAManual of Canine and Feline Nephrology and Urology, edited by J. Elliott and G.F. Grauer, 2nd edition. Gloucester, England: British Small Animal Veterinary Association, pp. 223-230.
25. Brown, S.A., et al. (2007b). Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 21: 542-558.
26. Brown, S.A., et al. (2003). Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am J Vet Res 64: 321-327.
27. Brown, S.A., et al. (1998). Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. J Lab Clin Med 131: 447-455.
28. Brown, S.A., et al. (2001). Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am J Vet Res 62: 375-383.
29. Brown, S.A., et al. (1995). Impaired renal autoregulatory ability in dogs with reduced renal mass. J Am Soc Nephrol 5: 1768-1774.
30. Brushinsky, D. (2005). Disorders of calcium and phosphorus homeostasis. In: Primer on Kidney Diseases, edited by A. Greenberg, 4th edition. San Diego, CA: Academic Press, pp. 120-130.
31. Buranakarl, C., et al. (2004). Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function. Am J Vet Res 65: 620-627.
32. Burkholder, W.J., et al. (2004). Dietmodulates proteinuria in heterozygous female dogs with X-linked hereditary nephropathy. J Vet Intern Med 18: 165-175.
33. Campbell, R., et al. (2003). Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 63: 1094-1103.
34. Canalejo, A., et al. (2003). Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol. Kidney Int 63:732-737.
35. Cheng, S. and D. Coyne (2007). Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 16: 77-82.
36. Combe, C. and M. Aparicio (1994). Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 46:1381-1386.
37. Cook, A. and L. Cowgill (1996). Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). J AmAnimHosp Assoc 32: 313-322.
38. Cook, S. and C. Lathrop (1994). Serum erythropoietin concentrations measured by radioimmunoassay in normal, polycythemic, and anemic dogs and cats. J Vet InternMed 8: 18-25.
39. Cowgill, L., et al. (1998). Use of recombinant humans erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 212: 521-528.
40. DeBowes, L., et al. (1996). Association of periodontal disease and histologic lesions in multiple organs from 45 dog. J Vet Dent 13:57-60.
41. DiBartola, S., et al. (1993). Development of chronic renal disease in cats fed a commercial diet. J AmVetMed Assoc 202: 744-751.
42. DiBartola, S., et al. (1987). Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc 190: 1196-1202.
43. Dow, S. and M. Fettman (1992). Renal disease in cats: the potassium connection. In: Current Veterinary Therapy XI, edited by R. Kirk. Philadelphia, PA:WB Saunders, pp. 820-822.
44. Dow, S., et al. (1990). Effects of dietary acidification and potassium depletion on acid-base balance, mineral metabolism and renal function in adult cats. J Nutr 120: 569-578.
45. Dow, S., et al. (1987). Potassium depletion in cats: renal and dietary influences. J AmVetMed Assoc 191: 1569-1575.
46. Elliot, J. et al. (2006). Symposium on PhosphatemiaManagement in the Treatment of Chronic Kidney Disease. Louisville, KY: Vetoquinol.
47. Elliott, J., et al. (2003a). Assessment of acid-base status of cats with naturally occurring chronic renal failure. J Small Anim Pract 44:65-70.
48. Elliott, J., et al. (2003b). Acid-base balance of cats with chronic renal failure: effect of deterioration in renal function. J Small Ani Pract 44: 261-268.
49. Elliot, J., et al. (2001). Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 42: 122-129.
50. Elliot, J. and P. Barber (1998). Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 39: 78-85.
51. Epstein, M. (2004). Aldosterone as a determinant of progressive renal dysfunction: a paradigm shift. Nephrol Self Assess Program 3: 285-295.
52. Epstein, M. (2001). Aldosterone as a mediator of progressive renal disease: pathogenic and clinical implications. Am J Kid Dis 37: 677-688.
53. Fliser, D., et al. (2007). Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study. J Am SocNephrol 18: 2601-2608.
54. Finco, D., et al. (1999). Progression of chronic renal disease in the dog. J Vet InternMed 13: 516-528.
55. Finco, D., et al. (1997). Effects of parathyroidectomy on induced renal failure in dogs. Am J Vet Res 58: 188-195.
56. Finco, D., et al. (1992). Effects of dietary phosphorus and protein in dogs with chronic renal failure. Am J Vet Res 53: 2264-2271.
57. Fettman, M., et al. (1992). Effect of dietary phosphoric acid supplementation on acid-base balance and mineral and bone metabolism in adult cats. Am J Vet Res 53: 2125-2135.
58. Freundlich, M., et al. (2008). Suppression of renin-angiotensin gene expression in the kidney by paracalcitol. Kidney Int 74: 1394-1402.
59. Gerber, B., et al. (2003). Serum concentrations of 1,25- dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure. Am J Vet Res 64: 1161-1166.
60. Goldstein, R., et al. (1998). Gastrin concentrations in plasma of cats with chronic renal failure. J AmVetMed Assoc 213: 826-828.
61. Grauer, G., et al. (2000). Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet InternMed 14:526-533.
62. Grodecki, K.M., et al. (1997). Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 117: 209-225.
63. Gutierrez, O., et al. (2005). Fibroblast growth factor-23 mitigates hyperphosphatemia but accelerates calcitriol deficiency in chronic kidney disease. J Am SocNephrol 16: 2205-2215.
64. Harris, R.C. and E.G. Neilson (2006). Toward a unified theory of renal progression. Annu Rev Med 57: 365-380.
65. Henik, R., et al. (1997). Treatment of systemic hypertension in cats with amlodipine besylate. J AmAnimHosp Assoc 33: 226-234.
66. Hilgers, K. and J. Mann (2002). ACE inhibitors versus AT1 receptor antagonists in patients with chronic renal disease. J Am SocNephrol 13: 1100-1108.
67. Hostetter, T., et al. (2001a). Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am SocNephrol 12:1315-1325.
68. Hostetter, T., et al. (2001b). Aldosterone in renal disease. Curr Opin Nephrol Hypertens 10: 105-110.
69. Hostutler, R.A., et al. (2006). Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and catswith chronic renal failure. J Vet InternMed 20: 1307-1313.
70. Iseki, K., et al. (2003). Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63: 1468-1474.
71. Israel, R., et al. (1986). Metoclopramide decreases renal plasma flow. Clin Pharmacol Ther 39: 261-264.
72. Jacob, F., et al. (2005). Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am VetMed Assoc 226: 393-400.
73. Jacob, F., et al. (2003). Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J AmVetMed Assoc 222: 322-329.
74. Jacob, F., et al. (2002). Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. J Am Vet Med Assoc 220(8): 1163-1170.
75. James, K., et al. (1997). Serum total carbon dioxide concentrations in canine and feline blood: the effect of underfilling blood tubes and comparisons with blood gas analysis as an estimate of plasma bicarbonate. Am J Vet Res 58: 343-347.
76. Jepson, R.E., et al. (2007). Effect of control of systolic blood pressure on survival in cats with systemic hypertension. J Vet InternMed 21:402-409.
77. Kappel, J. and C. Piera (2002). Safe drug prescribing for patients with renal insufficiency. Can J Med 166: 473-477.
78. Kates, D., et al. (1997). Evidence that serumphosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 30: 809-813.
79. Kazama, J.J., et al. (2005). Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism. Ther Apher Dial 9: 328-330.
80. King, J.N., et al. (2006). Tolerability and efficacy of benazepril in cats with chronic kidney disease. J Vet InternMed 20: 1054-1064.
81. King, J.N., et al. (2007). Prognostic factors in cats with chronic kidney disease. J Vet InternMed 21: 906-916.
82. King, L., et al. (1992). Anemia of chronic renal failure in dogs. J Vet Intern Med 6: 264-270.
83. Kogika, M.M., et al. (2006). Serum ionized calcium in dogs with chronic renal failure and metabolic acidosis. Vet Clin Pathol 35:441-445.
84. Kruger, J., et al. (1996). Hypercalcemia and renal failure. Vet Clin North Am 26: 1417-1445.
85. Kyles, A., et al. (1999). Management of hypertension controls postoperative neurological disorders after renal transplantation in cats. Vet Surg 28: 436-441.
86. Lappin, M.R., et al. (2005). Investigation of the induction of antibodies against Crandell-Rees feline kidney cell lysates and feline renal cell lysates after parenteral administration of vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia in cats. Am J Vet Res 66: 506-511.
87. Lappin, M.R., et al. (2006). Interstitial nephritis in cats inoculatedwith crandell rees feline kidney cell lysates. J Feline Med Surg 8: 353-356.
88. Lees, G.E., et al. (2005). Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J Vet InternMed 19: 377-385.
89. Lemarié, R., et al. (1995). Mast cell tumors: clinical management. Compend Cont Educ Pract Vet 17: 1085-1101.
90. Levey, A., et al. (1999). Dietary protein restriction and the progression of chronic renal disease: what have all the resuts of theMDRD study shown? J Am SocNephrol 10: 2426-2439.
91. Lopez-Hilker, S., et al. (1990). Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 259: F432-F437.
92. Lulich, J., et al. (1992). Feline renal failure: questions, answers, questions. Compend Cont Educ Pract Vet 14: 127-153.
93. Menon, V., et al. (2009). Effect of a very-low protein diet on outcomes:long-term follow-up of the modification of diet in renal disease (MDRD) study. Am J Kidney Dis 53: 208-217.
94. Mathur, S., et al. (2002). Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. Am J Vet Res 63: 833-839.
95. Minkus, G., et al. (1994). Evaluation of renal biopsies in cats and dogs - histopathology in comparison with clinical data. J Small Anim Pract 35: 465-472.
96. Mitch, W. (1997). Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr 67: 359-366.
97. Nagode, L., et al. (1996). Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure: both are essential to prevent or suppress toxic hyperparathyroidism. Vet Clin North Am 26: 1293-1330.
98. Nath, K. (1998). The tubulointerstitium in progressive renal disease. Kidney Int 54: 992-994.
99. Paoletti, E. and G. Cannella (2006). Update on erythropoietin treatment:should hemoglobin be normalized in patients with chronic kidney disease? J Am SocNephrol 17: S74-S77.
100. Papich, M.G. (2007). Saunders Handbook of Veterinary Drugs, 2nd edition. St. Louis, MO: WB Saunders, pp. 379-380.
101. Perkovic, L.D., et al. (2002). Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting. Kidney Blood Press Res 25: 61-64.
102. Peters, R.M., et al. (2005). Histopathologic features of canine uremic gastropathy: a retrospective study. J Vet InternMed 19: 315-320.
103. Pisoni, R. and G. Remuzzi (2001). Pathophysiology and management of progressive chronic renal failure. In: Primer on Kidney Diseases, edited by A. Greenberg, 3rd edition. San Diego, CA:NationalKidney Foundation, pp. 385-396.
104. Plantinga, E.A., et al. (2005). Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 157: 185-187.
105. Plumb, D.C. (2008). Plumb’s Veterinary Drug Handbook, 6th edition. Ames, IA: Blackwell Publishing, pp. 130-131
106. Poli, A., et al. (1995). Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation, and PCR analysis. Vet Immunol Immunopathol 46: 13-20.
107. Polzin, D., et al. (1988). Development of renal lesions in dogs after 11/12 reduction of renal mass: influence of dietary protein intake. Lab Invest 58: 172-183.
108. Pörsti, I.H. (2008). Expanding targets of vitaminDreceptor activation:downregulation of several RAS components in the kidney. Kidney Int 74: 1371-1373.
109. Randolph, J.E., et al. (2004). Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin. Am J Vet Res 65:1355-1366.
110. Randolph, J.E., et al. (2004a). Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J vet InternMed 18: 81-91.
111. Ravani, P., et al. (2009). VitaminDlevel and patient outcomein chronic kidney disease. Kidney Int 75: 88-95.
112. Remuzzi, G., et al. (2005). The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int 68(Suppl 99): S57-S65.
113. Remuzzi, A., et al. (2002). Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 62: 885-894.
114. Rennke, H.G. and B.M. (2007). Renal Pathophysiology: The Essentials, 2nd edition. Philadelphia, PA: Lippincott, Williams & Wilkins.
115. Ritz, E., et al. (2005). Role of calcium-phosphorus disorders in the progression of renal failure. Kidney Int 68 (Suppl 99): S66-S70.
116. Rosenberg, M. (2003). Chronic kidney disease: progression. Nephrol Self Assess Program 2: 89-103.
117. Ross, S.J., et al. (2006). Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 229: 949-957.
118. Sabatini, S. and N.A. Kurtzman (2009). Bicarbonate therapy in severe metabolic acidosis. J Am SocNephrol 20: 692-695.
119. Sato, A., et al. (2005). Antiproteinuric effects of mineralcorticoid receptor blockade in patients with chronic renal disease. Am J Hypertens 18: 44-49.
120. Segev, G., et al. (2008). Aluminum toxicity following administration of aluminum-based phosphate binders in 2 dogs with renal failure. J Vet InternMed 22: 1432-1435.
121. Schenck, P.A. and D.J. Chew (2003). Determination of calcium fractionation in dogs with chronic renal failure. Am J Vet Res 64:1181-1184.
122. Shoben, A.B., et al. (2008). Association of oral calcitriol with improved survival in nondialyzed CKD. J AmSocNephrol 19: 1613-1619.
123. Stevens, L.A. and A.S. Levey (2005). Chronic kidney disease: staging and principles of management. In: Primer on Kidney Diseases, edited by A. Greenberg, 4th edition. San Diego, CA: Academic Press, pp. 455-463.
124. Stiles, J., et al. (1994). The prevelance of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J Am Anim Hosp Assoc 30: 564-572.
125. Syme, H.M., et al. (2006). Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 20: 528-535.
126. Teruel, J., et al. (1996). Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. J Am Soc Nephrol 7: 140-144.
127. Theisen, S., et al. (1997). Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure. J Vet InternMed 11: 212-217.
128. Thomas, J., et al. (1993). Association of renal disease indicators with feline immunodeficiency virus infection. J Am Anim Hosp Assoc 29:320-326.
129. Vanholder, R. (1998). The uremic syndrome. In: Primer on KidneyDiseases, edited by A. Greenberg, 2nd edition. SanDiego, CA: Academic Press, pp. 403-407.
130. Weidemann, A. and R.S. Johnson (2009). Nonrenal regulation of EPO synthesis. Kidney Int 75: 682-688.
131. Weir, M. and J.C. Fink (2005). Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis 45: 176-188.
132. Wesson, D.E. and J. Simoni (2009). Increased tissue acid mediates a progressive decline in glomerular filtration rate of animals with reduced nephron mass. Kidney Int 75: 929-935.
133. Wolf, G., et al. (2002). Leptin and renal disease. Am J Kidney Dis 39:1-11.
134. Yudd, M. and F. Llach (2000). Current medical management of secondary hyperparathyroidism. Am J Med Sci 320: 100-106.